Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke - PubMed (original) (raw)
Review
Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke
Permphan Dharmasaroja. J Clin Neurosci. 2009 Jan.
Abstract
Bone marrow-derived mesenchymal stem cells (MSCs) have great potential as therapeutic agents in stroke management, since they are easily accessible and can be rapidly expanded ex vivo for autologous transplantation. Increasing evidence suggests that bone marrow cells migrate throughout the brain and differentiate into neurons and glial cells. Both non-human and human MSCs have been used to treat stroke in murine models with satisfactory results. Several factors, such as transdifferentiation, induction of neurogenesis and angiogenesis, neuroprotection, and activation of endogenous neurorestorative processes, contribute to the benefits of MSCs in the ischemic brain. Many variables, including types of MSCs, cell dose, timing of treatment, route of cell delivery, and characteristics of stroke patients, influence the efficacy of MSC treatment of stroke. Although the first trials of autologous MSC therapy in stroke patients showed promising results, the optimal approach for different clinical settings has yet to be determined. The fundamental properties of MSCs and their potential short-term and long-term toxicities also need to be determined before moving forward to use of these cells in clinical practice.
Similar articles
- Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats.
Koh SH, Kim KS, Choi MR, Jung KH, Park KS, Chai YG, Roh W, Hwang SJ, Ko HJ, Huh YM, Kim HT, Kim SH. Koh SH, et al. Brain Res. 2008 Sep 10;1229:233-48. doi: 10.1016/j.brainres.2008.06.087. Epub 2008 Jul 2. Brain Res. 2008. PMID: 18634757 - Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
Nimura A, Muneta T, Koga H, Mochizuki T, Suzuki K, Makino H, Umezawa A, Sekiya I. Nimura A, et al. Arthritis Rheum. 2008 Feb;58(2):501-10. doi: 10.1002/art.23219. Arthritis Rheum. 2008. PMID: 18240254 - Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine.
Tomar GB, Srivastava RK, Gupta N, Barhanpurkar AP, Pote ST, Jhaveri HM, Mishra GC, Wani MR. Tomar GB, et al. Biochem Biophys Res Commun. 2010 Mar 12;393(3):377-83. doi: 10.1016/j.bbrc.2010.01.126. Epub 2010 Feb 6. Biochem Biophys Res Commun. 2010. PMID: 20138833 - Mesenchymal stem cells: isolation, in vitro expansion and characterization.
Beyer Nardi N, da Silva Meirelles L. Beyer Nardi N, et al. Handb Exp Pharmacol. 2006;(174):249-82. Handb Exp Pharmacol. 2006. PMID: 16370331 Review. - Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications.
Arinzeh TL. Arinzeh TL. Foot Ankle Clin. 2005 Dec;10(4):651-65, viii. doi: 10.1016/j.fcl.2005.06.004. Foot Ankle Clin. 2005. PMID: 16297825 Review.
Cited by
- Safety and Efficacy of Bone Marrow Mesenchymal Stem Cells in the Treatment of Ischemic Stroke: A Meta-Analysis.
Zhang F, Wang Y. Zhang F, et al. Ann Indian Acad Neurol. 2024 Mar-Apr;27(2):131-139. doi: 10.4103/aian.aian_736_23. Epub 2024 Apr 5. Ann Indian Acad Neurol. 2024. PMID: 38751928 Free PMC article. - Mesenchymal stem cell therapy in ischemic stroke trials. A systematic review.
Moñivas Gallego E, Zurita Castillo M. Moñivas Gallego E, et al. Regen Ther. 2024 Apr 13;27:301-306. doi: 10.1016/j.reth.2024.03.026. eCollection 2024 Dec. Regen Ther. 2024. PMID: 38633415 Free PMC article. Review. - Early detection of optic nerve head changes using optical coherence tomography after using mesenchymal stromal cells as intravitreal therapy in rabbit models of ocular hypertension.
Evangelho KDS, Cifuentes-González C, Rojas-Carabali W, Vivero-Arciniegas C, Cañas-Arboleda M, Salguero G, Ramírez-Santana C, de-la-Torre A. Evangelho KDS, et al. Vet World. 2024 Feb;17(2):500-508. doi: 10.14202/vetworld.2024.500-508. Epub 2024 Feb 29. Vet World. 2024. PMID: 38595669 Free PMC article. - Bone Marrow Mesenchymal Stem Cell-Derived Exosomal KLF4 Alleviated Ischemic Stroke Through Inhibiting N6-Methyladenosine Modification Level of Drp1 by Targeting lncRNA-ZFAS1.
Wang QS, Xiao RJ, Peng J, Yu ZT, Fu JQ, Xia Y. Wang QS, et al. Mol Neurobiol. 2023 Jul;60(7):3945-3962. doi: 10.1007/s12035-023-03301-2. Epub 2023 Mar 31. Mol Neurobiol. 2023. PMID: 37002530 - Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti-_N_-Methyl-d-Aspartate Receptor Encephalitis: First Case Report.
Nguyen Thanh L, Hoang VT, Le Thu H, Nguyen PAT, Hoang DM, Ngo DV, Cao Vu H, Nguyen Thi Bich V, Heke M. Nguyen Thanh L, et al. Cell Transplant. 2022 Jan-Dec;31:9636897221110876. doi: 10.1177/09636897221110876. Cell Transplant. 2022. PMID: 35815930 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical